CommentaryDrug Development

An End to the Myth: There Is No Drug Development Pipeline

See allHide authors and affiliations

Science Translational Medicine  06 Feb 2013:
Vol. 5, Issue 171, pp. 171cm1
DOI: 10.1126/scitranslmed.3003505

Figures

  • Fig. 1. Using NETS to catch new therapies.

    This model provides a map for creating an open, collaborative, and coordinated system for drug development in the 21st century. Collaborative activities include basic science and therapeutic target discovery (orange and green), therapeutic discovery and nonclinical research (blue), regulatory science (purple), and clinical research (pink)—all of which impinge on a single goal: Patient access to modern therapeutic strategies. Dotted lines are work-arounds or alternative pathways. A map with links to resources is available online at www.geneticalliance.org/nets_fullview.

    CREDIT: RENDERED FROM AUTHORS’ MAP BY Y. HAMMOND/SCIENCE TRANSLATIONAL MEDICINE

Stay Connected to Science Translational Medicine

Navigate This Article